Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Pardes Biosciences Inc
About PRDS
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. Its lead product candidate, pomotrelvir, which targets the coronavirus disease (COVID-19). Pomotrelvir is in clinical development to treat COVID-19 in adult and pediatric patients. The Company, by leveraging its knowledge of structure-based drug design, reversible covalent chemistry and viral biology, it has discovered and is developing novel product candidates with low nanomolar potency against SARS-CoV-2 and activity against all known pathogenic human coronaviruses. Its lead product candidate, pomotrelvir, inhibits the main coronaviral cysteine protease (Mpro), a viral protein essential for replication of all known coronaviruses, including SARS-CoV-2. Inhibiting Mpro prevents the liberation and assembly of the viral replication complex, blocking replication before it begins.
Find out what a historical investment in Pardes Biosciences Inc would be worth today using our PRDS stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy PRDS shares in Australia?
Buying PRDS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Pardes Biosciences Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PRDS
What is the ticker symbol of Pardes Biosciences Inc?
The ticker symbol for Pardes Biosciences Inc is PRDS.
How much is one share of PRDS?
One share of PRDS is valued at $2.14 as of 11 June 2026.
What is the market capitalisation of Pardes Biosciences Inc PRDS?
As of 11 June 2026 Pardes Biosciences Inc has a market cap of -.
What is the 52-week high for Pardes Biosciences Inc stock?
The Pardes Biosciences Inc 52-week high stock price is $NaN.
What is the 52-week low for Pardes Biosciences Inc stock?
The Pardes Biosciences Inc 52-week low stock price is $NaN.
Can I buy PRDS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PRDS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRDS on Stake
- Buy PRDS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PRDS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PRDS related stocks